CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+30.05%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$647M
AUM Growth
+$647M
(+0.35%)
Cap. Flow
-$87.5M
Cap. Flow
% of AUM
-13.52%
Top 10 Holdings %
Top 10 Hldgs %
48.48%
Holding
75
New
6
Increased
14
Reduced
49
Closed
4
Top Buys
| 1 |
Alkermes
ALKS
|
$15.2M |
| 2 |
Bristol-Myers Squibb
BMY
|
$13.5M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$13.3M |
| 4 |
Heron Therapeutics
HRTX
|
$8.29M |
| 5 |
PFNX
Pfenex Inc.
PFNX
|
$7.57M |
Top Sells
| 1 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$41.5M |
| 2 |
CELG
Celgene Corp
CELG
|
$33.6M |
| 3 |
Puma Biotechnology
PBYI
|
$12.4M |
| 4 |
Neurocrine Biosciences
NBIX
|
$11.2M |
| 5 |
Tempest Therapeutics
TPST
|
$9.87M |
Sector Composition
| 1 | Healthcare | 72.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBPO
26
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $7.31M | 1.13% |
76,500
-13,500
| -15% | -$1.29M |
|
|
AGEN
27
Agenus
AGEN
$136M
| $7.23M | 1.12% |
71,789
+31,029
| +76% | +$3.12M |
|
|
FWP
28
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $7.22M | 1.12% |
36,429
+15,000
| +70% | +$2.97M |
|
29
Sangamo Therapeutics
SGMO
$161M
| $6.93M | 1.07% |
442,000
-58,000
| -12% | -$909K |
|
30
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $6.7M | 1.04% |
219,130
-3,070
| -1% | -$93.9K |
|
|
XLRN
31
DELISTED
Acceleron Pharma Inc.
XLRN
| $6.47M | 1% |
170,000
-80,000
| -32% | -$3.04M |
|
32
Ultragenyx Pharmaceutical
RARE
$3.04B
| $6.33M | 0.98% |
102,000
-18,000
| -15% | -$1.12M |
|
33
Curis
CRIS
$21.5M
| $6.32M | 0.98% |
26,320
+20,320
| +339% | +$4.88M |
|
|
ARRY
34
DELISTED
Array Biopharma Inc
ARRY
| $6.27M | 0.97% |
850,000
-150,000
| -15% | -$1.11M |
|
35
BioCryst Pharmaceuticals
BCRX
$1.74B
| $6.14M | 0.95% |
680,000
-120,000
| -15% | -$1.08M |
|
|
SCTL
36
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $5.95M | 0.92% |
731,336
-49,164
| -6% | -$400K |
|
|
APTO
37
DELISTED
Aptose Biosciences, Inc.
APTO
| $5.83M | 0.9% |
2,404
-3
| -0.1% | -$7.27K |
|
|
KITE
38
DELISTED
Kite Pharma, Inc.
KITE
| $5.77M | 0.89% |
100,000
-155,000
| -61% | -$8.94M |
|
39
Minerva Neurosciences
NERV
$16.8M
| $5.73M | 0.88% |
143,130
+121,255
| +554% | +$4.85M |
|
40
Iovance Biotherapeutics
IOVA
$800M
| $5.15M | 0.8% |
+424,815
| New | +$5.15M |
|
|
EPZM
41
DELISTED
Epizyme, Inc
EPZM
| $5M | 0.77% |
+266,250
| New | +$5M |
|
42
Lipocine
LPCN
$15.7M
| $4.6M | 0.71% |
+39,216
| New | +$4.6M |
|
43
Nektar Therapeutics
NKTR
$543M
| $4.37M | 0.68% |
26,500
-3,500
| -12% | -$578K |
|
|
GEVA
44
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $4.15M | 0.64% |
42,500
-57,500
| -58% | -$5.61M |
|
|
DRNA
45
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.09M | 0.63% |
170,000
-30,000
| -15% | -$721K |
|
|
CBIO
46
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $3.82M | 0.59% |
4,590
-133
| -3% | -$111K |
|
|
GNVC
47
DELISTED
GenVec, Inc.
GNVC
| $3.73M | 0.58% |
126,284
-6,646
| -5% | -$196K |
|
48
Rockwell Medical
RMTI
$59.6M
| $3.72M | 0.57% |
30,909
-5,455
| -15% | -$656K |
|
49
Dare Bioscience
DARE
$27.4M
| $3.62M | 0.56% |
3,345
-405
| -11% | -$438K |
|
50
Talphera
TLPH
$11.2M
| $3.28M | 0.51% |
42,500
-7,500
| -15% | -$579K |
|